[Vaccination in adult patients with chronic inflammatory rheumatic diseases]
- PMID: 23929239
- DOI: 10.1007/s00393-013-1155-4
[Vaccination in adult patients with chronic inflammatory rheumatic diseases]
Abstract
Patients with chronic inflammatory rheumatic diseases often have an intrinsic and therapy associated increased susceptibility to infections which substantially contributes to morbidity and mortality of the patients. A large proportion of these infections are preventable by vaccination. For this reason in 2005 the standing vaccination committee (STIKO) recommended for patients with immunosuppression vaccination against pneumococcus, influenza, Haemophilus influenza b and meningococcus in addition to standard vaccinations, independent of age. Every patient should therefore be informed about a possible increase in susceptibility to infections and the recommended prevention by vaccination before implementation of immunosuppressive therapy.
Similar articles
-
[Vaccination recommendations of the Commission for Pharmacotherapy of the German Society of Rheumatology].Z Rheumatol. 2013 Sep;72(7):687-9. doi: 10.1007/s00393-013-1154-5. Z Rheumatol. 2013. PMID: 23929238 German. No abstract available.
-
[Vaccination in adult rheumatology].Z Rheumatol. 2007 Mar;66(2):102-4, 106-10. doi: 10.1007/s00393-007-0144-x. Z Rheumatol. 2007. PMID: 17294061 Review. German.
-
[Immunization in children and adolescents with rheumatic diseases].Z Rheumatol. 2007 Mar;66(2):111-2, 114-8, 120. doi: 10.1007/s00393-007-0150-z. Z Rheumatol. 2007. PMID: 17364157 Review. German.
-
[Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].Z Rheumatol. 2013 Nov;72(9):896-909. doi: 10.1007/s00393-013-1203-0. Z Rheumatol. 2013. PMID: 23929242 German.
-
Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert.Arthritis Rheum. 2009 Nov 15;61(11):1505-10. doi: 10.1002/art.24873. Arthritis Rheum. 2009. PMID: 19877088
Cited by
-
[Psoriatic arthritis : Overview of drug therapy options and administration characteristics].Hautarzt. 2017 Feb;68(2):153-169. doi: 10.1007/s00105-016-3925-9. Hautarzt. 2017. PMID: 28083597 Review. German.
-
[B cell therapy of rheumatoid arthritis with rituximab. Practice-relevant aspects for the routine].Z Rheumatol. 2015 Apr;74(3):250-7. doi: 10.1007/s00393-014-1563-0. Z Rheumatol. 2015. PMID: 25854158 Review. German.
-
[Choosing wisely recommendations in rheumatology : One year after their first publication].Internist (Berl). 2017 Jun;58(6):580-584. doi: 10.1007/s00108-017-0247-7. Internist (Berl). 2017. PMID: 28488054 Review. German.
-
[Diagnosis and treatment of ANCA-associated vasculitis : S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for ENT Medicine and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.].Z Rheumatol. 2025 Apr;84(Suppl 1):1-49. doi: 10.1007/s00393-024-01597-6. Epub 2025 Apr 3. Z Rheumatol. 2025. PMID: 40178542 Review. German. No abstract available.
-
[Psoriatic arthritis : Overview of drug therapy options and administration characteristics].Z Rheumatol. 2016 Jun;75(5):471-88. doi: 10.1007/s00393-016-0110-6. Z Rheumatol. 2016. PMID: 27259913 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical